Pancreatic Digestive Enzyme Dispersion into Human Organs Outside the Gastrointestinal Tract. [PDF]
Chavan R, Schmid-Schönbein GW.
europepmc +1 more source
Identification of anoikis-related biomarkers linking immune infiltration to acute myocardial infarction. [PDF]
Zhao Y +6 more
europepmc +1 more source
A multi-cohort validated OXPHOS signature predicts survival and immune profiles in grade II/III glioma patients. [PDF]
Mou J +12 more
europepmc +1 more source
Bioinformatic analysis and validation of candidate genes in the eutopic endometrium reveal differential expressions in diffuse adenomyosis, endometrioma, and their co-existence. [PDF]
Mitra I +8 more
europepmc +1 more source
Integrative transcriptomics and single-cell transcriptomics analyses reveal potential biomarkers and mechanisms of action in papillary thyroid carcinoma. [PDF]
Cao W, Gao K, Zhao Y.
europepmc +1 more source
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects. [PDF]
Gurevich M +3 more
europepmc +1 more source
<i>PNPLA3</i> and <i>TM6SF2</i> exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis. [PDF]
Gensluckner S +19 more
europepmc +1 more source
Identification and characterisation of eight novel SERPINA1 null mutations.
openaire +1 more source
Related searches:
SERPINA1, generalized pustular psoriasis, and adult‐onset immunodeficiency
The Journal of Dermatology, 2021AbstractAdult‐onset immunodeficiency syndrome (AOID) with anti‐interferon (IFN)‐γ autoantibodies is characterized by an AIDS‐like illness with disruptive IFN‐γ signaling. Patients generally present with recurrent and disseminated opportunistic infections along with neutrophilic dermatoses.
Piranit Kantaputra +11 more
openaire +3 more sources
Protease inhibitor SERPINA1 expression in epithelial ovarian cancer
Clinical & Experimental Metastasis, 2010Epithelial ovarian cancer is the most lethal gynecologic cancer with a 5 years survival rate of 30-40% in patients diagnosed with high-grade invasive disease (TOV). This is in stark contrast to the 95% 5 years survival rate in ovarian cancer patients diagnosed with low malignant potential (LMP) disease.
Karine, Normandin +7 more
openaire +2 more sources

